Expanding the genetic spectrum of mitochondrial diseases in Tunisia: novel variants revealed by whole-exome sequencing

Front Genet. 2024 Jan 12:14:1259826. doi: 10.3389/fgene.2023.1259826. eCollection 2023.

Abstract

Introduction: Inherited mitochondrial diseases are the most common group of metabolic disorders caused by a defect in oxidative phosphorylation. They are characterized by a wide clinical and genetic spectrum and can manifest at any age. In this study, we established novel phenotype-genotype correlations between the clinical and molecular features of a cohort of Tunisian patients with mitochondrial diseases. Materials and methods: Whole-exome sequencing was performed on five Tunisian patients with suspected mitochondrial diseases. Then, a combination of filtering and bioinformatics prediction tools was utilized to assess the pathogenicity of genetic variations. Sanger sequencing was subsequently performed to confirm the presence of potential deleterious variants in the patients and verify their segregation within families. Structural modeling was conducted to study the effect of novel variants on the protein structure. Results: We identified two novel homozygous variants in NDUFAF5 (c.827G>C; p.Arg276Pro) and FASTKD2 (c.496_497del; p.Leu166GlufsTer2) associated with a severe clinical form of Leigh and Leigh-like syndromes, respectively. Our results further disclosed two variants unreported in North Africa, in GFM2 (c.569G>A; p.Arg190Gln) and FOXRED1 (c.1261G>A; p.Val421Met) genes, and we described the first case of fumaric aciduria in a Tunisian patient harboring the c.1358T>C; p.Leu453Pro FH variant. Conclusion: Our study expands the mutational and phenotypic spectrum of mitochondrial diseases in Tunisia and highlights the importance of next-generation sequencing to decipher the pathomolecular mechanisms responsible for these disorders in an admixed population.

Keywords: 3D structural modeling; Leigh syndrome; North Africa; Tunisia; fumaric aciduria; genetic diagnosis; mitochondrial diseases; whole-exome sequencing.

Grants and funding

The authors declare financial support was received for the research, authorship, and/or publication of this article. This project was supported by the French–Tunisian bilateral program PHC Utique 2022 MITORARE, Grant Number: 47634VH, CMCU: 22G0808; the Tunisian Ministry of Higher Education and Scientific Research (grant number LR16IPT05); the Tunisian Ministry of Health, the Institut National de la Santé et de la Recherche Médicale (INSERM); Centre National de la Recherche Scientifique (CNRS); the University of Angers, the University Hospital (CHU) of Angers; the Region Pays de Loire and Angers Loire Metropole in France; and the Tuniso–Marocain project 20/PRD-18.